260 - Group A Strep: Familiar Friend or Emerging Foe?

Saturday, October 19, 2024

3:15 PM – 4:30 PM US PT

Location: Ballroom (West Hall B)

All relevant financial relationships have been mitigated.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

Hilary Miller-Handley, MD (she/her/hers)

Assistant Professor
University of Cincinnati and Cincinnati Children's Hospital Medical Center
Cincinnati, OH, United States
Belinda Ostrowsky, MD, MPH, FIDSA, FSHEA

Field Medical Officer
Centers for Disease Control & Prevention & Einstein/ Montefiore
New York, NY, United States

Faculty(s)

Victor Nizet, MD (he/him/his)

Distinguished Professor and Vice Chair
Pediatrics
University of California San Diego
San Diego, CA, United States
Guliz Erdem, MD

Professor of Pediatrics
Nationwide Children's Hospital
Columbus, OH, United States
Kathryn Como-Sabetti, MPH

Epidemiology Manager
Minnesota Department of Health
St Paul, MN, United States

Disclosure(s):

Hilary Miller-Handley, MD: No financial relationships to disclose

Belinda Ostrowsky, MD, MPH, FIDSA, FSHEA: No financial relationships to disclose

Victor Nizet, MD: Cellics Therapeutics: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing), Stock Options (Ongoing); Clarametyx Biosciences: Advisor/Consultant (Ongoing), Stock Options (Ongoing); Vaxcyte, Inc.: Grant/Research Support (Ongoing), The have licensed a vaccine patent from UC San Diego on which I am an inventor (Ongoing)

Guliz Erdem, MD: No financial relationships to disclose

Kathryn Como-Sabetti, MPH: No financial relationships to disclose

Learning Objectives:

At the conclusion of this session, participants will be able to:

analyze recent laboratory and research up dates regarding group a streptococcal (gas) disease;
investigate the epidemiology and increases in gas disease;
describe clinical presentations and treatment of gas disease;
analyze the management of gas in vulnerable settings including long term care facilities.

Presentations:

3:15 PM – 3:40 PM US PT

Group A Streptococcus: Molecular Pathogenesis of Invasive Infection and Efforts Toward a Preventative Vaccine
Speaker: Victor Nizet, MD (he/him/his) – University of California San Diego
3:40 PM – 4:05 PM US PT

Group A Streptococci; Clinical Stories from the Frontline
Speaker: Guliz Erdem, MD – Nationwide Children's Hospital
4:05 PM – 4:30 PM US PT

What Happens Outside, Affects Inside: Controlling clusters of GAS in vulnerable healthcare settings
Speaker: Kathryn Como-Sabetti, MPH – Minnesota Department of Health